Daye
London
About Daye
Daye is a gynecological health company that creates products and services for vaginal treatment. Its tampon-based at-home vaginal microbiome screening kit allows women to test themselves at their leisure. The kit is intended to screen for vaginal infections such as thrush and bacterial vaginosis (BV), as well as disruptions to the microbiome, which could put women at risk of STIs, gynecological cancers, and fertility and IVF complications. Daye will also launch a comprehensive digital platform for gynae health, with the goal of reducing pain, shame, and wasted time for women as they navigate their health journey from their first period to menopause. The company was founded in 2017
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2022)
- Website: yourdaye.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Cannabis, Health Care, Personal Health, Women's
Social Profiles
Canonical: https://fsome.com/organization/daye-53762 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.